80066-70-2

Basic information

• Product Name: 3-Isoquinolinecarboxylicacid,5-amino-,methylester(9CI)
• Synonyms: 3-Isoquinolinecarboxylicacid,5-amino-,methylester(9CI);Methyl 5-aMinoisoquinoline-3-carboxylate
• CAS NO: 80066-70-2
• Molecular Formula: C₁₁H₁₀N₂O₂
• Molecular Weight: 202.21
• Product Categories: AMINOACID
• Mol File: 80066-70-2.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Isoquinolinecarboxylicacid,5-amino-,methylester(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Isoquinolinecarboxylicacid,5-amino-,methylester(9CI)(80066-70-2)
• EPA Substance Registry System: 3-Isoquinolinecarboxylicacid,5-amino-,methylester(9CI)(80066-70-2)

Safety Data

• Hazardous Substances Data: 80066-70-2(Hazardous Substances Data)

Usage

General Description

3-Isoquinolinecarboxylic acid, 5-amino-, methylester (9CI) is a chemical compound with the molecular formula C11H10N2O2. It is an ester of 5-aminonicotinic acid with a methyl group. 3-Isoquinolinecarboxylicacid,5-amino-,methylester(9CI) is commonly used in the synthesis of various pharmacologically active compounds, such as antipsychotic and antimalarial drugs. It is also used as a building block in the production of various organic compounds. Additionally, this chemical may have potential applications in medicinal chemistry and drug development due to its structural properties and pharmacological activities.

Upstream product

• 27104-73-0 methyl isoquinoline-3-carboxylate 
• 80066-71-3 5-aminoisoquinoline-3-carboxylic acid 
• 581812-72-8 Methyl 5-nitroisoquinoline-3-carboxylate 
• 7439-89-6 iron 

Downstream Products

• 1005029-80-0 methyl 5-iodoisoquinoline-3-carboxylate 

Relevant articles and documents

Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor

Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.

Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor

Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.

Thiazolo[3,4-b]isoquinolines

Isoquinoline derivatives of the formula STR1 wherein the symbol A1 represents an isoquinol-8-yl, 3-methylisoquinol-8-yl, 3-hydroxymethylisoquinol-5-yl, 3-carboxymethylisoquinol-5-yl, quinol-5-yl, thienopyridyl, benzimidazolyl, thienyl or thiazolyl radical, a 4-(or 5-)carboxyalkylthiazol-2-yl radical in which the alkyl moiety is linear or branched and contains 1 to 4 carbon atoms, or a 1,3,4-thiadiazol-2-yl, pyrazolyl, imidazolyl, pyrimidinyl, pyridazinyl or pyrazinyl radical, monocyclic heterocyclic rings within the definition of A1 being optionally substituted by a linear or branched alkyl radical containing 1 to 4 carbon atoms, in the (S) or (R,S) form or mixtures thereof, and salts thereof possess useful pharmocological properties, in particular antiviral activity.